Marinomed Biotech AG - ESG Rating & Company Profile powered by AI
The ESG score includes seventeen United Nations SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. If you work at Marinomed Biotech AG and you wish to use your Sustainability aseessment, please get in touch. Alternative companies in the scoring industry group for Marinomed Biotech AG are displayed.
Marinomed Biotech AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 2.7, social score of 8.0 and governance score of 8.0.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 427 | Scancell Holdings PLC | 6.3 | High |
| 427 | Verastem Inc | 6.3 | High |
| 450 | Marinomed Biotech AG | 6.2 | High |
| 450 | Cannasouth Ltd | 6.2 | High |
| 450 | CareDx International AB | 6.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Marinomed Biotech AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Marinomed Biotech AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Marinomed Biotech AG report the average age of the workforce?
Sign up for free to unlockDoes Marinomed Biotech AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Marinomed Biotech AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Marinomed Biotech AG disclose cybersecurity risks?
Sign up for free to unlockDoes Marinomed Biotech AG offer flexible work?
Sign up for free to unlockDoes Marinomed Biotech AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Marinomed Biotech AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Marinomed Biotech AG conduct supply chain audits?
Sign up for free to unlockDoes Marinomed Biotech AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Marinomed Biotech AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Marinomed Biotech AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Marinomed Biotech AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Marinomed Biotech AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Marinomed Biotech AG disclose water use targets?
Sign up for free to unlockDoes Marinomed Biotech AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Marinomed Biotech AG have a product recall in the last two years?
Sign up for free to unlockDoes Marinomed Biotech AG disclose incidents of discrimination?
Sign up for free to unlockDoes Marinomed Biotech AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Marinomed Biotech AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Marinomed Biotech AG disclose parental leave metrics?
Sign up for free to unlockDoes Marinomed Biotech AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Marinomed Biotech AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Marinomed Biotech AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Marinomed Biotech AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Marinomed Biotech AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Marinomed Biotech AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Marinomed Biotech AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Marinomed Biotech AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Marinomed Biotech AG disclose its waste policy?
Sign up for free to unlockDoes Marinomed Biotech AG report according to TCFD requirements?
Sign up for free to unlockDoes Marinomed Biotech AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Marinomed Biotech AG disclose energy use targets?
Sign up for free to unlockDoes Marinomed Biotech AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Marinomed Biotech AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Marinomed Biotech AG
These potential risks are based on the size, segment and geographies of the company.
Marinomed Biotech AG, a biopharmaceutical company, develops therapies for patients suffering from serious viral infectious diseases and autoreactive immune disorders in Austria, other European countries, and internationally. It operates through two segments, Carragelose and Marinosolv. The company develops Marinosolv, a technology platform that increases the bioavailability of hardly soluble compounds for the treatment of sensitive tissues, such as eyes and nose; and. Its products pipeline includes Tacrosolv, which is in Phase II clinical trial for anterior inflammatory eye diseases; Inhaleen that is in Phase I clinical trial for viral pneumonia; Budesolv, which has completed Phase III clinical trial for treatment of allergic rhinitis; Flutisolv that is Phase II clinical trials for inflammatory diseases of nose; and Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.